Low immunoglobulin levels increase the risk of severe hypogammaglobulinemia in granulomatosis with polyangiitis patients receiving rituximab
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Low immunoglobulin levels increase the risk of severe hypogammaglobulinemia in granulomatosis with polyangiitis patients receiving rituximab
Authors
Keywords
ANCA-associated vasculitis, Rituximab, Induction, Maintenance, Immunoglobulin, Hypogammaglobulinemia, Discontinuation, Adverse event, Principal component analysis, Correspondence analysis
Journal
BMC MUSCULOSKELETAL DISORDERS
Volume 17, Issue 1, Pages -
Publisher
Springer Nature
Online
2016-01-06
DOI
10.1186/s12891-015-0860-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Rituximab-associated hypogammaglobulinemia: Incidence, predictors and outcomes in patients with multi-system autoimmune disease
- (2015) Darren M. Roberts et al. JOURNAL OF AUTOIMMUNITY
- Reconstitution of the peripheral B lymphocyte compartment in patients with ANCA-associated vasculitides treated with rituximab for relapsing or refractory disease
- (2014) Nils Venhoff et al. AUTOIMMUNITY
- Long-Term Maintenance Therapy Using Rituximab-Induced Continuous B-Cell Depletion in Patients with ANCA Vasculitis
- (2014) W. F. Pendergraft et al. Clinical Journal of the American Society of Nephrology
- Rituximab for induction and maintenance therapy in granulomatosis with polyangiitis (Wegener's). Results of a single-center cohort study on 66 patients
- (2014) Ana Luisa Calich et al. JOURNAL OF AUTOIMMUNITY
- Rituximab versus Azathioprine for Maintenance in ANCA-Associated Vasculitis
- (2014) Loïc Guillevin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Long-term follow-up of patients who received repeat-dose rituximab as maintenance therapy for ANCA-associated vasculitis
- (2014) Federico Alberici et al. RHEUMATOLOGY
- Serum immunoglobulin levels and risk factors for hypogammaglobulinaemia during long-term maintenance therapy with rituximab in patients with granulomatosis with polyangiitis
- (2014) Emilio Besada et al. RHEUMATOLOGY
- Induction treatment of ANCA-associated vasculitis with a single dose of rituximab
- (2014) T. Turner-Stokes et al. RHEUMATOLOGY
- Single-dose rituximab for remission induction and maintenance therapy in ANCA-associated vasculitis: a retrospective analysis of 17 patients
- (2014) P Moog et al. SCANDINAVIAN JOURNAL OF RHEUMATOLOGY
- Rituximab With or Without a Conventional Maintenance Agent in the Treatment of Relapsing Granulomatosis With Polyangiitis (Wegener's): A Retrospective Single-Center Study
- (2014) Lama Azar et al. Arthritis & Rheumatology
- Efficacy and safety of rituximab as maintenance therapy for relapsing granulomatosis with polyangiitis—a case series
- (2013) A. Knight et al. CLINICAL RHEUMATOLOGY
- Long-term efficacy and safety of pre-emptive maintenance therapy with rituximab in granulomatosis with polyangiitis: results from a single centre
- (2013) Emilio Besada et al. RHEUMATOLOGY
- Rituximab for induction and maintenance treatment of ANCA-associated vasculitides: a multicentre retrospective study on 80 patients
- (2013) P. Charles et al. RHEUMATOLOGY
- Rituximab for remission induction and maintenance in refractory granulomatosis with polyangiitis (Wegener's): Ten-year experience at a single center
- (2012) Rodrigo Cartin-Ceba et al. ARTHRITIS AND RHEUMATISM
- Rituximab for remission maintenance in relapsing antineutrophil cytoplasmic antibody-associated vasculitis
- (2012) Rona M. Smith et al. ARTHRITIS AND RHEUMATISM
- Efficacy and Safety of Rituximab Treatment in Patients with Antineutrophil Cytoplasmic Antibody-associated Vasculitides: Results from a German Registry (GRAID)
- (2012) P. ROLL et al. JOURNAL OF RHEUMATOLOGY
- Impact of Rituximab on Immunoglobulin Concentrations and B Cell Numbers after Cyclophosphamide Treatment in Patients with ANCA-Associated Vasculitides
- (2012) Nils Venhoff et al. PLoS One
- Off-Trial Evaluation of the B cell-Targeting Treatment in the Refractory Cases of Antineutrophil Cytoplasmic Antibodies (ANCA)-Associated Vasculitis: Long-Term Follow-Up from a Single Centre
- (2012) R. Pullerits et al. SCANDINAVIAN JOURNAL OF IMMUNOLOGY
- Long-Term Effects of Rituximab Added to Cyclophosphamide in Refractory Patients with Vasculitis
- (2011) Dario Roccatello et al. AMERICAN JOURNAL OF NEPHROLOGY
- Rituximab for refractory granulomatosis with polyangiitis (Wegener's granulomatosis): comparison of efficacy in granulomatous versus vasculitic manifestations
- (2011) Julia U Holle et al. ANNALS OF THE RHEUMATIC DISEASES
- Long-term follow-up of different refractory systemic vasculitides treated with rituximab
- (2011) Frances Rees et al. CLINICAL RHEUMATOLOGY
- Rituximab Maintenance Therapy for Granulomatosis with Polyangiitis and Microscopic Polyangiitis
- (2011) C. ROUBAUD-BAUDRON et al. JOURNAL OF RHEUMATOLOGY
- Prolonged disease-free remission following rituximab and low-dose cyclophosphamide therapy for renal ANCA-associated vasculitis
- (2011) N. Mansfield et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Rituximab in relapsing or refractory ANCA-associated vasculitis: a case series of 16 patients
- (2011) M Wendt et al. SCANDINAVIAN JOURNAL OF RHEUMATOLOGY
- Rituximab as Maintenance Therapy for Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
- (2010) E. P. Rhee et al. Clinical Journal of the American Society of Nephrology
- Rituximab versus Cyclophosphamide for ANCA-Associated Vasculitis
- (2010) John H. Stone et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rituximab versus Cyclophosphamide in ANCA-Associated Renal Vasculitis
- (2010) Rachel B. Jones et al. NEW ENGLAND JOURNAL OF MEDICINE
- A multicenter survey of rituximab therapy for refractory antineutrophil cytoplasmic antibody-associated vasculitis
- (2009) Rachel B. Jones et al. ARTHRITIS AND RHEUMATISM
- Rituximab is effective in the treatment of refractory ophthalmic Wegener's granulomatosis
- (2009) Simon R. J. Taylor et al. ARTHRITIS AND RHEUMATISM
- Translational Mini-Review Series on B Cell-Directed Therapies: B cell-directed therapy for autoimmune diseases
- (2009) C. Hu et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started